Please Wait.....
Report
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
Market Report I 2024-04-15 I 195 Pages I MarketsandMarkets
The global robotic radiotherapy market is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period. The rising prevalence of cancer and the growing use of robotic radiotherapy is one of the major factors anticipated to boost market growth in the forecasting years.
"3D cameras (SGRT) segment of global robotic radiotherapy market to grow with the highest CAGR in the forecast period."
On the basis of product, the robotic radiotherapy market is segmented into radiotherapy systems, software, 3D cameras, and others. The 3D cameras segment is expected to register the highest CAGR in the forecast period. Growth in this segment is majorly driven by the ability to offer non-invasive, real-time, 6-degree dimensional patient positioning and monitoring before and during the radiation therapy treatment process, resulting in accurate treatment delivery and wide acceptance by cancer facilities. However, factors such as significant maintenance costs associated with SGRT products, as well as the slow implementation of regulatory guidelines for robotic radiotherapy across emerging countries, are expected to restrain market growth.
"Lung cancer segment, by application, accounted for the largest market share of global robotic radiotherapy market in 2020."
Based on application, the global robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. The major drivers of this segment are increasing smoking rates, exposure to air pollutants, especially in urban areas with poor air quality, and exposure to carcinogens in mining, construction, and manufacturing. Modern lifestyles and dietary habits may further elevate the risk of lung cancer. As the global population ages, lung cancer incidence tends to rise, potentially leading to a higher number of cases.
"Increased installations and government initiatives to drive the segment growth of hospitals end-user segment."
Based on the end user, the robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers. Hospitals are the major end users of robotic radiotherapy products. The large share of this end-user segment is primarily attributed to the demand for automated radiation therapy systems, advancement in automated radiation therapy systems and the increasing installations of ART stations, and the rising government investments for effective ART and treatment.
"The APAC market, by region, to register highest growth rate in the forecast period."
On the basis of region, the robotic radiotherapy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia-Pacific market is likely witness significant growth owing to increase in disposable income and increase in cancer patient pool. Focus on governments on investment on robotic radiotherapy systems, modernization of industrial and public infrastructures, and rising penetration of cutting-edge radiation therapy in hospitals. However, a dearth of skilled professionals for the operation of advanced instruments, slow implementation of therapy due to budgetary constraints, and pricing pressures faced by prominent product manufacturers are the key factors restraining the growth of the robotic radiotherapy market despite the great opportunities available in the APAC region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
- By Designation: C-level-10%, Director-level-14%, and Others-76%
- By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, MEA- 3%
The prominent players in the robotic radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), C-RAD (Sweden), IBA Worldwide (Belgium), Hitachi Ltd. (Japan (US), Mevion Medical Systems (US), Optivus Proton Therapy, Inc. (US) and Panacea Medical Technologies Pvt. Ltd. (India), among others.
Research Coverage
This report studies the robotic radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (growing demand for non-invasive treatments, technological advancements, rising prevalence of cancer, growing use of automated radiation therapy for cancer treatment), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, complex nature of technology, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries, growing government and private investments, adoption of radiation therapy), and challenges (risk of radiation exposure, competition from alternative treatment modalities) influencing the growth of robotic radiotherapy market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the robotic radiotherapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the robotic radiotherapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
1.3.2 GEOGRAPHIES COVERED 23
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 24
1.4 LIMITATIONS 24
1.5 MARKET STAKEHOLDERS 25
1.5.1 RECESSION IMPACT 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
2.2 RESEARCH DESIGN 27
2.2.1 SECONDARY RESEARCH 27
2.2.2 PRIMARY RESEARCH 29
2.2.2.1 Primary sources 29
2.2.2.2 Key data from secondary sources 30
2.2.2.3 Breakdown of primaries 30
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 30
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 32
2.3.1 BOTTOM-UP APPROACH 32
2.3.1.1 Approach 1: Company revenue estimation approach 33
FIGURE 4 MARKET SIZE ESTIMATION FOR ROBOTIC RADIOTHERAPY: APPROACH 1 (COMPANY REVENUE ESTIMATION) 33
2.3.1.2 Approach 2: Customer-based market estimation 33
FIGURE 5 ROBOTIC RADIOTHERAPY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 34
2.3.1.3 Approach 3: Top-down approach 34
2.3.1.4 Approach 4: Primary interviews 34
2.3.2 TOP-DOWN APPROACH 35
2.4 DATA VALIDATION APPROACH 37
FIGURE 6 DATA TRIANGULATION METHODOLOGY 37
2.5 MARKET SHARE ASSESSMENT 38
2.6 STUDY ASSUMPTIONS 38
2.7 RISK ASSESSMENT 38
TABLE 1 LIMITATIONS AND ASSOCIATED RISKS 38
2.8 GROWTH RATE ASSUMPTIONS 38
2.9 RECESSION IMPACT ANALYSIS 39
3 EXECUTIVE SUMMARY 40
FIGURE 7 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 40
FIGURE 8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 41
FIGURE 9 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 41
FIGURE 10 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 42
FIGURE 11 GEOGRAPHICAL SNAPSHOT: ROBOTIC RADIOTHERAPY MARKET 43
4 PREMIUM INSIGHTS 44
4.1 ROBOTIC RADIOTHERAPY MARKET OVERVIEW 44
FIGURE 12 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS TO DRIVE MARKET 44
4.2 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 45
FIGURE 13 RADIOTHERAPY SYSTEMS TO DOMINATE MARKET IN 2028 45
4.3 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY AND END USER, 2022 (USD MILLION) 45
FIGURE 14 HOSPITALS DOMINATED END-USER MARKET IN 2022 45
4.4 ROBOTIC RADIOTHERAPY MARKET: COMPARISON OF COUNTRY-WISE GROWTH RATES 46
FIGURE 15 INDIA AND CHINA TO SHOW HIGHEST GROWTH DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 16 ROBOTIC RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Rising prevalence of cancer 48
TABLE 2 PROJECTED INCREASE IN CANCER CASES, 2020-2040 48
5.2.1.2 Growing demand for noninvasive treatment 48
5.2.2 RESTRAINTS 49
5.2.2.1 Premium Product Pricing 49
5.2.2.2 Complexities associated with automated/robotic radiotherapy 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Rising healthcare expenditure across emerging economies 50
5.2.3.2 Government and private investments to boost cancer treatment availability 50
5.2.4 CHALLENGES 51
5.2.4.1 Risk of radiation exposure 51
5.2.4.2 Dearth of skilled personnel 51
5.3 TECHNOLOGY ANALYSIS 52
5.4 PORTER'S FIVE FORCES ANALYSIS 52
TABLE 3 ROBOTIC RADIOTHERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS 52
5.4.1 THREAT OF NEW ENTRANTS 52
5.4.2 THREAT OF SUBSTITUTES 53
5.4.3 BARGAINING POWER OF SUPPLIERS 53
5.4.4 BARGAINING POWER OF BUYERS 53
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 53
5.5 KEY STAKEHOLDERS AND BUYING CRITERIA 53
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 53
FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS 53
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%) 54
5.6 REGULATORY ANALYSIS 54
5.6.1 US 54
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 55
5.6.2 EUROPE 55
5.6.3 JAPAN 55
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 56
5.7 REIMBURSEMENT SCENARIO 56
TABLE 7 CPT CODES FOR IMRT 56
TABLE 8 CPT CODES FOR SBRT 57
TABLE 9 CPT CODES FOR PROTON BEAM THERAPY 57
TABLE 10 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022 58
TABLE 11 PROPOSED AMBULATORY PAYMENT CLASSIFICATION 2023 RATES 58
TABLE 12 IMPACT OF CLINICAL LABOR PRICE CHANGES ON RADIATION ONCOLOGY SERVICES 59
5.8 ECOSYSTEM ANALYSIS 59
5.9 VALUE CHAIN ANALYSIS 60
5.9.1 RESEARCH & DEVELOPMENT 60
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT 60
5.9.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES 60
FIGURE 18 VALUE CHAIN ANALYSIS IN ROBOTIC RADIOTHERAPY MARKET 61
5.10 SUPPLY CHAIN ANALYSIS 62
5.10.1 PROMINENT COMPANIES 62
5.10.2 SMALL & MEDIUM-SIZED COMPANIES 62
5.10.3 END USERS 62
FIGURE 19 SUPPLY CHAIN ANALYSIS OF ROBOTIC RADIOTHERAPY MARKET 62
5.11 PRICING ANALYSIS 63
TABLE 13 PRICING ANALYSIS OF RADIOTHERAPY SYSTEMS (USD) 63
5.12 PATENT ANALYSIS 64
FIGURE 20 TOP TEN PATENT APPLICANTS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2022) 64
FIGURE 21 TOP TEN PATENT INVENTORS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023) 64
FIGURE 22 TOP TEN PATENT OWNERS FOR RADIOTHERAPY (JANUARY 2012 TO JUNE 2023) 65
5.13 TRADE ANALYSIS 65
TABLE 14 IMPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018-2022 (USD THOUSAND) 65
TABLE 15 EXPORT DATA FOR RADIOTHERAPY SYSTEMS (HS CODE 9022), BY COUNTRY, 2018-2022 (USD THOUSAND) 66
5.14 KEY CONFERENCES AND EVENTS IN 2022-2023 67
TABLE 16 ROBOTIC RADIOTHERAPY MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2022-2023 67
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 68
FIGURE 23 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX 68
6 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT 69
6.1 INTRODUCTION 70
TABLE 17 ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 70
6.2 RADIOTHERAPY SYSTEMS 70
6.2.1 RISING USE OF AI AND AUTOMATION TO DRIVE MARKET 70
TABLE 18 RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2020-2028 (USD MILLION) 71
6.3 SOFTWARE 71
6.3.1 NEED TO ENSURE TREATMENT EFFECTIVENESS AND ACCURACY TO BOOST GROWTH 71
TABLE 19 SOFTWARE MARKET, BY REGION, 2020-2028 (USD MILLION) 72
6.4 3D CAMERAS 72
6.4.1 GROWING USE OF SGRT TO DRIVE DEMAND 72
TABLE 20 3D CAMERAS MARKET, BY REGION, 2020-2028 (USD MILLION) 72
6.5 OTHER PRODUCTS 73
TABLE 21 OTHER ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020-2028 (USD MILLION) 73
7 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY 74
7.1 INTRODUCTION 75
TABLE 22 ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020-2028 (USD MILLION) 75
7.2 LINEAR ACCELERATORS 75
TABLE 23 LINEAR ACCELERATORS MARKET, BY TYPE, 2020-2028 (USD MILLION) 75
7.2.1 CONVENTIONAL LINEAR ACCELERATORS 76
7.2.1.1 Longer treatment duration to limit adoption 76
7.2.2 MRI LINEAR ACCELERATORS 76
7.2.2.1 Rising awareness about benefits to enhance demand 76
7.3 STEREOTACTIC RADIATION THERAPY 76
TABLE 24 STEREOTACTIC RADIATION THERAPY MARKET, BY TYPE, 2020-2028 (USD MILLION) 77
7.3.1 CYBERKNIFE 77
7.3.1.1 Precision and correction capabilities to boost adoption 77
7.3.2 GAMMA KNIFE 77
7.3.2.1 Ongoing product development to drive market 77
7.4 PARTICLE THERAPY SYSTEMS 78
TABLE 25 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020-2028 (USD MILLION) 78
7.4.1 PROTON BEAM THERAPY 78
7.4.1.1 Rising establishment of proton therapy cancer centers to drive market 78
7.4.2 HEAVY ION THERAPY 79
7.4.2.1 Limited number of facilities to slow growth 79
8 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION 80
8.1 INTRODUCTION 81
TABLE 26 ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020-2028 (USD MILLION) 81
8.2 LUNG CANCER 81
8.2.1 LUNG CANCER TO DOMINATE APPLICATIONS MARKET 81
TABLE 27 ROBOTIC RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2020-2028 (USD MILLION) 82
8.3 BREAST CANCER 82
8.3.1 INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET 82
TABLE 28 ROBOTIC RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020-2028 (USD MILLION) 82
8.4 PROSTATE CANCER 83
8.4.1 PREFERENCE FOR NONINVASIVE TREATMENT TO BOOST GROWTH 83
TABLE 29 ROBOTIC RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020-2028 (USD MILLION) 83
8.5 HEAD & NECK CANCER 83
8.5.1 GROWING UTILIZATION OF CYBERKNIFE FOR TREATMENT TO DRIVE MARKET 83
TABLE 30 ROBOTIC RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2020-2028 (USD MILLION) 84
8.6 COLORECTAL CANCER 84
8.6.1 RISING INCIDENCE OF COLORECTAL CANCER TO SUPPORT GROWTH 84
TABLE 31 ROBOTIC RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2020-2028 (USD MILLION) 85
8.7 OTHER CANCERS 85
TABLE 32 ROBOTIC RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020-2028 (USD MILLION) 85
9 ROBOTIC RADIOTHERAPY MARKET, BY END USER 86
9.1 INTRODUCTION 87
TABLE 33 ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020-2028 (USD MILLION) 87
9.2 HOSPITALS 87
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET 87
TABLE 34 ROBOTIC RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2020-2028 (USD MILLION) 88
9.3 INDEPENDENT RADIOTHERAPY CENTERS 88
9.3.1 LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION 88
TABLE 35 ROBOTIC RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2020-2028 (USD MILLION) 88
10 ROBOTIC RADIOTHERAPY MARKET, BY REGION 89
10.1 INTRODUCTION 90
TABLE 36 ROBOTIC RADIOTHERAPY MARKET, BY REGION, 2020-2028 (USD MILLION) 90
10.2 NORTH AMERICA 90
10.2.1 NORTH AMERICA: RECESSION IMPACT 90
FIGURE 24 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT 91
TABLE 37 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020-2028 (USD MILLION) 92
TABLE 38 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 92
TABLE 39 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020-2028 (USD MILLION) 92
TABLE 40 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020-2028 (USD MILLION) 93
TABLE 41 NORTH AMERICA: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020-2028 (USD MILLION) 93
10.2.2 US 93
10.2.2.1 US to dominate North American market over forecast period 93
TABLE 42 US: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 94
10.2.3 CANADA 94
10.2.3.1 Increasing government initiatives and favorable reimbursement to drive market 94
TABLE 43 CANADA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 94
10.3 EUROPE 95
10.3.1 EUROPE: RECESSION IMPACT 95
TABLE 44 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020-2028 (USD MILLION) 95
TABLE 45 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 96
TABLE 46 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020-2028 (USD MILLION) 96
TABLE 47 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020-2028 (USD MILLION) 97
TABLE 48 EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020-2028 (USD MILLION) 97
10.3.2 GERMANY 97
10.3.2.1 Increasing aging population and rising life expectancy to drive market 97
TABLE 49 GERMANY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 98
10.3.3 FRANCE 98
10.3.3.1 Well-developed healthcare sector and rising geriatric population to drive market 98
TABLE 50 FRANCE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 98
10.3.4 UK 99
10.3.4.1 High burden of chronic diseases to support adoption 99
TABLE 51 UK: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 99
10.3.5 ITALY 99
10.3.5.1 Increasing geriatric population to drive market 99
TABLE 52 ITALY: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 99
10.3.6 SPAIN 100
10.3.6.1 Technological developments in healthcare to drive market 100
TABLE 53 SPAIN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 100
10.3.7 REST OF EUROPE 100
TABLE 54 REST OF EUROPE: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 101
10.4 ASIA PACIFIC 101
10.4.1 ASIA PACIFIC: RECESSION IMPACT 101
FIGURE 25 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET SNAPSHOT 102
TABLE 55 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY COUNTRY, 2020-2028 (USD MILLION) 103
TABLE 56 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 103
TABLE 57 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020-2028 (USD MILLION) 104
TABLE 58 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020-2028 (USD MILLION) 104
TABLE 59 ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020-2028 (USD MILLION) 105
10.4.2 JAPAN 105
10.4.2.1 Rising geriatric population and surgical procedures to drive market 105
TABLE 60 JAPAN: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 105
10.4.3 CHINA 106
10.4.3.1 Developing healthcare infrastructure to drive market 106
TABLE 61 CHINA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 106
10.4.4 INDIA 106
10.4.4.1 Rising awareness and government support to boost growth 106
TABLE 62 INDIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 107
10.4.5 AUSTRALIA 107
10.4.5.1 Well-established healthcare system to favor adoption 107
TABLE 63 AUSTRALIA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 108
10.4.6 SOUTH KOREA 108
10.4.6.1 Growing target patient population to drive market 108
TABLE 64 SOUTH KOREA: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 108
10.4.7 REST OF ASIA PACIFIC 109
TABLE 65 REST OF ASIA PACIFIC: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 109
10.5 REST OF THE WORLD 109
10.5.1 REST OF THE WORLD: RECESSION IMPACT 109
TABLE 66 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY PRODUCT, 2020-2028 (USD MILLION) 110
TABLE 67 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020-2028 (USD MILLION) 110
TABLE 68 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY APPLICATION, 2020-2028 (USD MILLION) 111
TABLE 69 REST OF THE WORLD: ROBOTIC RADIOTHERAPY MARKET, BY END USER, 2020-2028 (USD MILLION) 111
11 COMPETITIVE LANDSCAPE 112
11.1 OVERVIEW 112
11.2 KEY PLAYER STRATEGIES 112
FIGURE 26 KEY DEVELOPMENTS IN ROBOTIC RADIOTHERAPY MARKET (2019 TO 2023) 113
11.3 REVENUE ANALYSIS 114
FIGURE 27 REVENUE ANALYSIS OF TOP FIVE PLAYERS (2019-2022) 114
11.4 MARKET SHARE ANALYSIS: ROBOTIC RADIOTHERAPY MARKET, BY KEY PLAYER (2022) 114
FIGURE 28 ROBOTIC RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022 114
TABLE 70 ROBOTIC RADIOTHERAPY MARKET: DEGREE OF COMPETITION 115
11.5 COMPANY EVALUATION MATRIX (2022) 116
11.5.1 STARS 116
11.5.2 PERVASIVE PLAYERS 116
11.5.3 EMERGING LEADERS 116
11.5.4 PARTICIPANTS 116
FIGURE 29 ROBOTIC RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022 117
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 118
11.6.1 PROGRESSIVE COMPANIES 118
11.6.2 DYNAMIC COMPANIES 118
11.6.3 RESPONSIVE COMPANIES 118
11.6.4 STARTING BLOCKS 118
FIGURE 30 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 119
11.7 COMPETITIVE BENCHMARKING 120
11.7.1 OVERALL COMPANY FOOTPRINT 120
TABLE 71 OVERALL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET 120
11.7.2 COMPANY PRODUCT FOOTPRINT 121
TABLE 72 PRODUCT FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET 121
11.7.3 COMPANY REGIONAL FOOTPRINT 122
TABLE 73 REGIONAL FOOTPRINT ANALYSIS: ROBOTIC RADIOTHERAPY MARKET 122
11.8 COMPETITIVE SCENARIO (2019-2023) 123
11.8.1 PRODUCT LAUNCHES & APPROVALS 123
11.8.2 DEALS 123
11.8.3 OTHER DEVELOPMENTS 124
12 COMPANY PROFILES 125
12.1 KEY PLAYERS 125
(Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats)*
12.1.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.) 125
TABLE 74 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 125
FIGURE 31 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 126
12.1.2 ELEKTA 133
TABLE 75 ELEKTA: COMPANY OVERVIEW 133
FIGURE 32 ELEKTA: COMPANY SNAPSHOT (2022) 134
12.1.3 ACCURAY INCORPORATED 140
TABLE 76 ACCURAY INCORPORATED: COMPANY OVERVIEW 140
FIGURE 33 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022) 141
12.1.4 VIEWRAY TECHNOLOGIES, INC. 145
TABLE 77 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW 145
FIGURE 34 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 146
12.1.5 C-RAD 150
TABLE 78 C-RAD: COMPANY OVERVIEW 150
FIGURE 35 C-RAD: COMPANY SNAPSHOT (2022) 151
12.1.6 IBA 153
TABLE 79 IBA: COMPANY OVERVIEW 153
FIGURE 36 IBA: COMPANY SNAPSHOT (2022) 154
12.1.7 HITACHI LTD. 157
TABLE 80 HITACHI LTD.: COMPANY OVERVIEW 157
FIGURE 37 HITACHI LTD.: COMPANY SNAPSHOT (2021) 158
12.1.8 MEVION MEDICAL SYSTEMS 160
TABLE 81 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW 160
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 163
TABLE 82 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW 163
12.1.10 P-CURE 164
TABLE 83 P-CURE: COMPANY OVERVIEW 164
12.1.11 PROVISION HEALTHCARE 165
TABLE 84 PROVISION HEALTHCARE: COMPANY OVERVIEW 165
12.1.12 SUMITOMO HEAVY INDUSTRY LTD. 166
TABLE 85 SUMITOMO HEAVY INDUSTRY LTD.: COMPANY OVERVIEW 166
FIGURE 38 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2021) 167
12.1.13 PHILIPS HEALTHCARE 169
TABLE 86 PHILIPS HEALTHCARE: COMPANY OVERVIEW 169
FIGURE 39 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2022) 170
12.1.14 RAYSEARCH LABORATORIES 172
TABLE 87 RAYSEARCH LABORATORIES: COMPANY OVERVIEW 172
FIGURE 40 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022) 173
12.1.15 PROTOM INTERNATIONAL, INC. 176
TABLE 88 PROTOM INTERNATIONAL, INC.: COMPANY OVERVIEW 176
12.1.16 OPTIVUS PROTON THERAPY, INC. 177
TABLE 89 OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW 177
12.1.17 TOSHIBA CORPORATION 178
TABLE 90 TOSHIBA CORPORATION: COMPANY OVERVIEW 178
FIGURE 41 TOSHIBA CORPORATION: COMPANY SNAPSHOT (2022) 179
12.1.18 VISION RT LTD. 181
TABLE 91 VISION RT LTD.: COMPANY OVERVIEW 181
12.1.19 ADVANCED ONCOTHERAPY PLC 183
TABLE 92 ADVANCED ONCOTHERAPY PLC: COMPANY OVERVIEW 183
12.1.20 MIM SOFTWARE INC. 184
TABLE 93 MIM SOFTWARE INC.: COMPANY OVERVIEW 184
*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 186
12.2.1 STANDARD IMAGING, INC. 186
12.2.2 BRAINLAB AG 186
12.2.3 MAGNETTX ONCOLOGY SOLUTIONS LTD. 187
12.2.4 PTW FREIBURG GMBH 187
12.2.5 DOSISOFT SA 188
13 APPENDIX 189
13.1 DISCUSSION GUIDE 189
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 194
13.3 CUSTOMIZATION OPTIONS 196
13.4 RELATED REPORTS 197
13.5 AUTHOR DETAILS 198
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security